Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05093764 · ClinicalTrials.gov registry record · NA
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
A NA study of Aortic Valve Disease, sponsored by Saint Luke's Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05093764: Recruiting NA study of Aortic Valve Disease, sponsored by Saint Luke's Health System.
NCT05093764 is a NA study of Aortic Valve Disease that is actively recruiting participants, run by Saint Luke's Health System. The registered enrollment target is 20 participants, below the 18,616-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05093764, a NA study of Aortic Valve Disease, is actively recruiting participants, sponsored by Saint Luke's Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to quantify the amount of debris captured by the SENTINEL transcatheter cerebral embolic protection (TCEP) device in patients undergoing valve in valve transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF)
Conditions Studied
Interventions
- DEVICE VIV TAVR with BVF using TCEP
Study Locations (1)
Missouri
- Saint Luke's Hospital of Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT05093764 shows while recruiting
NCT05093764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 18,616-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Aortic Valve Disease appearing as the primary indexed condition, and to 1 intervention - of which VIV TAVR with BVF using TCEP is the first listed.
NCT05093764 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05093764 about?
NCT05093764 is a clinical study titled "Quantification of Debris Captured Using TCEP During VIV TAVR With BVF". The objective of this study is to quantify the amount of debris captured by the SENTINEL transcatheter cerebral embolic protection (TCEP) device in patients undergoing valve in valve transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF)
What is the current status of trial NCT05093764?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-02. Estimated completion is 2025-12-31.
What conditions does trial NCT05093764 study?
This clinical trial studies the following conditions: Aortic Valve Disease.
What interventions are being tested in trial NCT05093764?
The interventions under investigation include: VIV TAVR with BVF using TCEP (DEVICE).
Who is sponsoring clinical trial NCT05093764?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05093764 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05093764's enrollment target sits among peer trials
20 15th of 15 the lowest of 15 other Aortic Valve Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Valve Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The JenaValve ALIGN-AR LVAD Registry
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
-
Avalus Ultra Post-Approval Study (PAS)
ACTIVE NOT RECRUITING · NA
-
J-Valve TF Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
ACTIVE NOT RECRUITING · NA
-
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI